Literature DB >> 25611279

Giant ovarian mucinous cystadenoma with borderline areas: a case report.

Monica Mihaela Cîrstoiu1, Maria Sajin, Diana Cristina Secară, Octavian Munteanu, Florin Cătălin Cîrstoiu.   

Abstract

Nowadays, giant ovarian mucinous cystadenomas are a rare condition, due to early diagnose and treatment. We report the case of a 44-year-old patient, who was diagnosed and admitted in our department with a giant pelvi-abdominal mass. The patient was operated with very high-risk consent, thus an enormous ovarian cyst of approximately 30 kg was extirpated. Afterwards, an extensive histopathological analysis was performed in order to determine the exact clinicopathological entity of the giant tumor-enteric type of multilocular mucinous ovarian cyst adenoma with borderline areas, with benign proliferation. Although giant ovarian mucinous cyst adenoma with borderline areas is an extremely rare condition, when encountered it is a real challenge for both surgeon and pathologist.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25611279

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  4 in total

1.  Giant ovarian cyst masquerading as a massive ascites: a case report.

Authors:  Eugene Vernyuy Yeika; Derrick Tembi Efie; Paul Nkemtendong Tolefac; Joseph Nkeangu Fomengia
Journal:  BMC Res Notes       Date:  2017-12-19

2.  A 27-kg mucinous cystadenoma of the ovary presenting with deep vein thrombosis.

Authors:  Esra Nur Tola; Evrim Erdemoğlu; Yakup Yalçın; Filiz Alkaya Solmaz; Ebru Erdemoğlu
Journal:  Turk J Obstet Gynecol       Date:  2016-03-10

3.  Giant mucinous ovarian borderline tumor. A good lesson from an asymptomatic case.

Authors:  Vincenzo Pilone; Salvatore Tramontano; Pierpaolo Picarelli; Angela Monda; Mafalda Romano; Michele Renzulli; Carmen Cutolo
Journal:  Int J Surg Case Rep       Date:  2018-07-26

4.  Giant Ovarian Cysts Treated by Single-Port Laparoscopic Surgery: A Case Series.

Authors:  Lili Jiang; Xinyu Zhao; Yue Han; Kuiran Liu; Xinyue Meng
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.